What a difference a month can make, especially for new acting Health and Human Services Secretary Don Wright.
“We will ask HHS leadership,” Wright wrote as part of a response letter to the watchdog agency for his department in reference to a report on whistle-blower protections.
• Sept. 29: The White House designates him as acting HHS secretary to replace Tom Price, who resigned over his use of private jets with taxpayer dollars.
Over the course of a single lunar cycle, Wright went from asking that guy to being that guy. This, of course, has huge implications for Medicare- and Medicaid-related things, for which you should follow my colleagues Sara Hansard, Alex Ruoff, Victoria Pelham and others about.
His appointment could also potentially be good news for research. As the acting assistant secretary of health, Wright oversaw the HHS offices in human research protections and research integrity. He was also the acting research integrity director at one point.
This experience in research oversight could be handy as the status of the Common Rule remains on hold. These are the regulations designed to protect people from experiencing undue harm in research by making sure, in part, they are aware of what’s going on before any testing on them begins. They also underwent a massive revision, which took more than five years to accomplish and marked the first-ever update to the Common Rule in three decades.
The Obama administration dropped that new rule on its last day in office, and initially thought institutions would have a year to get up to speed. But the Trump administration almost immediately issued a regulatory freeze on all midnight rules—this one is about as midnight as you can get.
The final rule removed most of the controversial stuff, so there isn’t necessarily an issue with the content of the rule. Meanwhile, months have gone by, nothing else has happened, and the rule is supposed to go into effect in a little more than three months, on Jan. 19, 2018. It’s still under a review by administration officials within the department.
What does this mean for the regulated community? I have a feeling this will be coming up at the final meeting of the year for the HHS Secretary Advisory’s Committee on Human Research Protections. It is most definitely coming up in San Antonio in early November when Public Responsibility in Medicine & Research takes its annual conference there.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)